Increasing the efficiency of depression-screening using patient-targeted feedback: Randomized controlled trial

Increasing the efficiency of depression-screening using patient-targeted feedback: Randomized controlled trial - DEPSCREEN-INFO

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003277

Enrollment

3500

Registered

2012-07-03

Start date

2011-10-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 I25 I10

Interventions

Group 1: state-of-art depression screening plus patient-targeted feedback Group 2: state-of-art depression screening

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Attendance in a cardiac clinic; Clinical diagnosis of coronary heart disease or hypertension; Age = 18 years; Sufficient language skills; Informed consent

Exclusion criteria

Exclusion criteria: Life threatening health status; Severe somatic or/and psychological disorder that needs urgent treatment; Acute suicidal tendency; Severe cognitive or/and visual difficulties; Not being able to fill out questionnaires

Design outcomes

Secondary

Measure	Time frame
Level of depression six months after screening (PHQ-9); Proportion of patients treated for depression, direct and indirect health costs, quality-adjusted years of life and quality of life (EQ-5D) one month and six months after screening.	—

Primary

Measure	Time frame
Level of depression one month after screening (PHQ-9)	—

Countries

Germany

Contacts

Public ContactBernd Löwe

Institut und Poliklinik für Psychosomatische Medizin und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf

b.loewe@uke.de+49-40-7410-59733

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026